Catalyst Wire Dossier Catalyst Wire Dossier

NYMALIZE

Nimodipine · Azurity Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for NYMALIZE, covering 2013-05-10 to 2024-08-28. Get the full timeline:

Most recent: FDA Approved: NYMALIZE — Supplemental Application (Azurity Pharmaceuticals, Inc.)

See pricing